Krishna Gundabolu, MBBS

Assistant Professor

  • 464 Citations
  • 10 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Krishna Gundabolu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Anticoagulants Medicine & Life Sciences
Venous Thromboembolism Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 464 Citations
  • 10 h-Index
  • 20 Article
  • 4 Review article
  • 3 Comment/debate
  • 1 Letter

Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients

Michalski, J. M., Lyden, E. R., Lee, A. J., Al-Kadhimi, Z. S., Maness-Harris, L. J., Gundabolu, K. & Bhatt, V. R., Jun 1 2019, In : Future Oncology. 15, 17, p. 1989-1995 7 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
decitabine
Drug Therapy
Survival
Therapeutics
Acute Myeloid Leukemia
1 Citation (Scopus)

Atypical chronic myeloid leukemia: A rare entity with management challenges

Dhakal, P., Gundabolu, K., Amador, C., Rayamajhi, S. & Bhatt, V. R., Jan 1 2018, In : Future Oncology. 14, 2, p. 177-185 9 p.

Research output: Contribution to journalReview article

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Bone Marrow
Mutation
Basophils
Manuscripts

Factors associated with receipt of hematopoietic cell transplantation for acute lymphoblastic leukemia

Manikkam Umakanthan, J., Chen, B., Gundabolu, K. & Bhatt, V. R., Jun 1 2018, In : Future Oncology. 14, 13, p. 1253-1260 8 p.

Research output: Contribution to journalArticle

Cell Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Medicaid
Medicare
Insurance
9 Citations (Scopus)

NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Bockenstedt, P. L., Chesney, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Gundabolu, K., Hendrie, P., Lee, A. I., Lee, J. T., Mann, J., McMahon, B., Millenson, M. M., Morton, C., Ortel, T. L. & 12 others, Ozair, S., Paschal, R., Shattil, S., Siddiqi, T., Smock, K. J., Soff, G., Wang, T. F., Williams, E., Zakarija, A., Hammond, L., Dwyer, M. A. & Engh, A. M., Nov 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 11, p. 1289-1303 15 p.

Research output: Contribution to journalArticle

Venous Thromboembolism
Guidelines
Neoplasms
Second Primary Neoplasms
Anticoagulants